Intestinal Ultrasound Feasible for Detecting Pediatric Inflammatory Bowel Disease
FRIDAY, Jan. 3, 2025 -- Intestinal ultrasound (IU) can be considered a screening tool for pediatric inflammatory bowel disease (IBD), according to a study published online Dec. 24 in the Journal of Pediatric Gastroenterology and Nutrition.
Hamza Hassan Khan, M.D., from the Medical University of South Carolina in Charleston, and colleagues compared IU findings to clinical disease, fecal calprotectin (FC), and endoscopic findings in newly diagnosed pediatric IBD patients. The analysis included 50 pediatric patients (median age, 13.5 years) undergoing colonoscopy (50 percent with IBD).
The researchers found that IU sensitivity was 76 percent, specificity 84 percent, positive predictive value 83 percent, and negative predictive value 78 percent for diagnosing IBD. For detection of moderate-to-severe disease, performance was 91.3, 86.21, 84.0, and 92.6 percent, respectively. There was a significant correlation seen between IU and FC, the Mayo score, and Simple Endoscopic Score (0.513, 0.565, and 0.731, respectively). Pearson correlations for the Pediatric Ulcerative Colitis Activity Index and Pediatric Crohn's Disease Activity Index scores were 0.070 and −0.159, respectively.
"IU can be considered a screening tool for pediatric IBD," the authors write. "Larger multicenter studies are needed in pediatrics to establish pediatric-specific scoring systems and support responses to treatment algorithms."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Parent-Focused Interventions Do Not Prevent Obesity at Age 24 Months
TUESDAY, Sept. 16, 2025 -- Parent-focused behavioral interventions seem to be insufficient for preventing obesity at age 24 months, according to a review published online Sept. 10...
Half Discontinue Semaglutide for Weight Loss Within One Year
TUESDAY, Sept. 16, 2025 -- Half of adults who start semaglutide for weight loss discontinue within a year, according to a study presented at the annual meeting of the European...
Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment
MONDAY, Sept. 15, 2025 -- In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.